Recovery of sensitivity to cisplatinum and epidoxorubicin by ionidamine and interferon in advanced ovarian-cancer.

Abstract

Eighteen patients with advanced ovarian cancer not or no longer responding to cisplatinum and epidoxorubicin including combination chemotherapy were retreated with the above two drugs in combination with lonidamine and interferon, administered with the aim of restoring chemosensitivity. Overall response rate was 32%, with one durable complete response and… (More)

Topics

Cite this paper

@article{Iaffaioli1994RecoveryOS, title={Recovery of sensitivity to cisplatinum and epidoxorubicin by ionidamine and interferon in advanced ovarian-cancer.}, author={R Vincenzo Iaffaioli and Anna Tortoriello and Gaetano Facchini and Francesco Caponigro and Paola Mastrantonio and Maria Luisa Barzelloni and G. Gesue and Giovanna Mantovani and M P Sant{\'a}ngelo}, journal={International journal of oncology}, year={1994}, volume={4 6}, pages={1265-9} }